On the recordNovember 16, 2020
I ask unanimous consent that the bill be considered read a third time and passed and that the motion to reconsider be considered made and laid upon the table. The PRESIDING OFFICER. Without objection, it is so ordered. The bill (S. 4612) was ordered to be engrossed for a third reading, was read the third time, and passed, as follows S. 4612 Be it enacted by the Senate and House of Representatives of the United States of America in Congress assembled, SECTION 1. SHORT TITLE. This Act may be cited as the ``Methamphetamine Response Act of 2020''. SEC. 2. FINDINGS. Congress finds the following: (1) Methamphetamine poses a significant public health and safety threat and qualifies as an emerging drug threat, as defined in section 702 of the Office of National Drug Control Policy Reauthorization Act of 1998 (21 U.S.C. 1701). (2) Methamphetamine treatment admissions increased from 15.1 percent of all admissions in 2008 to 23.6 percent in 2017, the latest year for which data is available. (3) During the timeframe described in paragraph (2)-- (A) methamphetamine-related treatment admissions among women increased from 19.2 percent of all drug-related treatment admissions to 28.3 percent; and (B) heroin use among those admitted for methamphetamine- related treatment increased from 5.3 percent to 23.6 percent. (4) By the end of 2019, methamphetamine availability, use, purity, and potency had increased nationally, as street-level prices declined.…
Source
govinfo.gov




